Serum Anti-mullerian Hormone and Polycystic Ovarian Syndrome
Serum Anti-mullerian Hormone and Polycystic Ovarian Syndrome
In 1935 the polycystic ovary syndrome was a clinical diagnosis made on the morphological
 appearance of the ovaries in association with amenorrhoea, hirsutism and frequently obesity.
 At that time wedge resection of the ovaries was introduced on an empirical basis and proved a
 successful treatment for the associated anovulation and infertility. In the ensuing fifty
 years the limitations of a purely surgical approach to therapy have become recognized and the
 importance of the biochemical abnormalities appreciated. Prevalence of polycystic Ovary
 Syndrome: The prevalence of polycystic ovary syndrome in any specified population is
 dependent upon the diagnostic criteria used, but does have some regional and ethnic
 variation. While most reports on the prevalence of polycystic ovary syndrome range between 2
 and 20%, the chosen diagnostic criteria are recognized to influence the determined
 prevalence. Anti-mullerian hormone which is a predictor of ovarian reserve is known to
 decrease after laparoscopic ovarian drilling. On the best of our knowledge no study had been
 done to use the level of anti-mullerian hormone as a factor for planning the number of
 ovarian drills in each ovary.
Inclusion Criteria:

 1. Infertility more than 2 years.

 2. Age between 20-35 years.

 3. clomiphene resistant patients: Patients received clomiphene 150 mg from day 3 to 7 of
 the menstrual cycle for 6 months and non-ovulatory (with failure of conception). They
 were followed up in the outpatient clinic.

 4. No contraindications for laparoscopy.

 5. Normal Hysterosalpingography

 Exclusion Criteria:

 1. Contraindications for laparoscopy e.g cardiac diseases, bad scared abdomen ect….

 2. Women's age less than 20 years or more than 35 years.

 3. Previous Laparoscopic surgery.

 4. Previous ovarian surgery.

 5. Women with Antimullerian hormone level less than 4 ng/ml.

 6. Tubal factor infertility as diagnosed by Hysterosalpingography .